The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis
Abstract
BACKGROUND: Available treatments for lymphatic filariasis (LF) are limited in their longterm clearance of microfilaria from the blood. The safety and efficacy of a single-dose triple-drug therapy of the antifilarial drugs diethylcarbamazine (DEC), ivermectin (IVM), and albendazole (ALB) for LF are unknown. METHODS: We performed a pilot study to test the efficacy, safety, and pharmacokinetics of single-dose DEC, IVM, and ALB in Wuchereria bancrofti-infected Papua New Guineans. Adults were randomized into 2 treatment arms, DEC 6 mg/kg + ALB 400 mg (N = 12) or DEC 6 mg/kg + ALB 400 mg + IVM 200 μg/kg (N = 12), and monitored for microfilaria, parasite antigenemia, adverse events (AEs), and serum drug levels. RESULTS: Triple-drug therapy induced >2-log reductions in microfilaria levels at 36 and 168 hours after treatment compared with approximately 1-log reduction with 2 drugs. All 12 individuals who received 3 drugs were microfilaria negative 1 year after treatment, whereas 11 of 12 individuals in the 2-drug regimen were microfilaria positive. In 6 participants followed 2 years after treatment, those who received 3 drugs remained microfilaria negative. AEs, particularly fever, myalgias, pruritus, and proteinuria/hematuria, occurred in 83% vs 50% of those receiving triple-drug compared to 2-drug treatment respectively (P = .021); all resolved within 7 days after treatment. No serious AEs were observed in either group. There was no significant effect of IVM on DEC or ALB drug levels. CONCLUSIONS: Triple-drug therapy is safe and more effective than DEC + ALB for Bancroftian filariasis and has the potential to accelerate elimination of lymphatic filariasis. CLINICAL TRIALS REGISTRATION: NCT01975441.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lymphatic filariasis and onchocerciasis
Taylor, M. J., Hoerauf, A., & Bockarie, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60586-7 · Cited by 686
Awadzi, K., Edwards, G., Duke, B. O. L., Opoku, N. O., Attah, S. K., Addy, E. T., Ardrey, A. E., & Quartey, B. T. (2003) · Annals of Tropical Medicine & Parasitology · doi:10.1179/000349803235001697 · Cited by 61
Cited by
Ivermectin – Old Drug, New Tricks?
Laing, R., Gillan, V., & Devaney, E. (2017) · Trends in Parasitology · doi:10.1016/j.pt.2017.02.004 · Cited by 410
Neglected tropical diseases: progress towards addressing the chronic pandemic
Molyneux, D. H., Savioli, L., & Engels, D. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30171-4 · Cited by 376
The public health control of scabies: priorities for research and action.
Engelman, D., Cantey, P. T., Marks, M., Solomon, A. W., Chang, A. Y., Chosidow, O., Enbiale, W., Engels, D., Hay, R. J., Hendrickx, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31136-5 · Cited by 223
Integrated Management of Skin NTDs—Lessons Learned from Existing Practice and Field Research
Yotsu, R. R. (2018) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed3040120 · Cited by 65
Albendazole and Praziquantel: Review and Safety Monitoring in Korea
Hong, S.-T. (2018) · Infection & Chemotherapy · doi:10.3947/ic.2018.50.1.1 · Cited by 65
Metadata
- Authors
- Thomsen, E. K., Sanuku, N., Baea, M., Satofan, S., Maki, E., Lombore, B., Schmidt, M. S., Siba, P. M., Weil, G. J., Kazura, J. W., Fleckenstein, L. L., & King, C. L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10-20
- Volume
- 62
- Issue
- 3
- Pages
- 334-341
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2181101964
- Cited by
- 186
- References
- 2
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis. https://app.cochat.ai/papers/10.1093/cid/civ882
- The paper
- Thomsen, E. K., Sanuku, N., Baea, M., Satofan, S., Maki, E., Lombore, B., Schmidt, M. S., Siba, P. M., Weil, G. J., Kazura, J. W., Fleckenstein, L. L., & King, C. L. (2016). Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis. Clinical Infectious Diseases. https://doi.org/10.1093/cid/civ882
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.